CancerMay 16, 2026
Cologuard catches about 92% of colorectal cancers from a stool sample you collect at home, with no bowel prep, no fasting, and no sedation. The whole process happens in your bathroom and ends with a prepaid box dropped at FedEx.
That convenience is the entire point. ((colonoscopy:Colonoscopy)) still finds and removes polyps that Cologuard only flags from a distance, but the most invasive screening test in modern medicine is also the one people most often skip. Cologuard exists for the gap between "I should get screened" and "I scheduled the colonoscopy," and using it well takes about ten minutes spread across one bowel movement.
Cardiovascular HealthMay 16, 2026
You've just been told you have heart disease. Or maybe you've known for years and you're wondering whether you're doing enough. Either way, you're asking the right question: what actually works?
The answer, it turns out, depends a lot on what kind of heart disease you have, how severe it is, and what you're willing to do. Some treatments have decades of evidence behind them. Others are newer and surprisingly effective. And some widely used approaches don't work as well as most people assume.
Pain ManagementMay 16, 2026
A 25 mg dose of diclofenac potassium provides the same pain relief as 400 mg of ibuprofen with comparable short-term safety. That's a striking ratio: roughly one-sixteenth the milligrams for equivalent effect. The potassium salt formulation also absorbs faster and more predictably than the more common diclofenac sodium, which means quicker onset when you're dealing with pain that demands immediate attention.
Diclofenac potassium works by inhibiting COX enzymes (the proteins that drive prostaglandin production, which triggers pain, inflammation, and fever). It's the same core mechanism as ibuprofen and other NSAIDs. What sets it apart is how the potassium salt dissolves: greater water solubility translates to faster, more consistent absorption, and that matters when you're sitting in a dark room with a migraine or recovering from surgery.
GLP-1May 16, 2026
In a head-to-head trial of 338 adults with obesity, weekly semaglutide reduced body weight by about 16% while daily liraglutide reached just 6% over the same 68 weeks. That gap matters. The choice of GLP-1 drug, the dose, and how long you stay on it collectively determine whether you lose a modest amount of weight or a quarter of your starting body mass.
GLP-1 receptor agonists have become the most effective non-surgical weight loss treatments ever tested in large trials. But the category includes several different drugs with meaningfully different results, and the details determine what you can realistically expect.
Weight ManagementMay 16, 2026
A 1.6-gram dose of beta-alanine triggers pins-and-needles tingling on the arms, neck, and trunk in most people who take it as a powder or solution. Put the same 1.6 grams in a sustained-release tablet and the tingling drops to roughly placebo levels. Same molecule, same dose, very different experience.
The form you take matters more than the amount.
If you take pre-workout, you probably know the feeling: that crawling tingle that hits your scalp, ears, or upper chest a few minutes after the scoop goes down. It is not an allergy and it is not a warning sign. It is one of the cleanest examples in neuroscience of a single molecule activating a single receptor on a specific kind of skin nerve.
Once you know what is going on, the workaround is obvious.
GLP-1May 16, 2026
In a trial of 27,564 patients followed for over two years, evolocumab (Repatha) cut LDL cholesterol by 59% and lowered major cardiovascular events by 15%, with no meaningful difference in adverse events versus placebo aside from a small uptick in injection-site reactions. Weight loss was not on the list of effects, then or in any subsequent analysis.
If you have heard that an injectable drug helps with weight, you are probably thinking of a different class. Wegovy, Zepbound, Ozempic, and Mounjaro are GLP-1 receptor agonists, designed specifically to drive weight loss. Repatha was designed for cholesterol.
They are all injections, administered weekly or monthly, and all expensive. They do not do the same thing.
Cardiovascular HealthMay 16, 2026
In a world where heart disease remains the leading cause of death, few tests carry as much weight or confusion as the cardiac stress test. It is routinely ordered to assess whether someone has coronary artery disease, but increasingly, people are asking a broader question: what does this test say about how long I might live?
This is where things get murky. While the stress test is a reliable diagnostic tool for uncovering hidden heart blockages, its real power may lie in what it reveals about your overall cardiovascular fitness. The trouble is, interpreting those results through the lens of longevity is not always straightforward.
Lab TestingMay 16, 2026
In a screening study of 23,485 people, almost 17% had a borderline hemoglobin A2 result between 3.1% and 3.9%, landing in the gray zone where the standard threshold for diagnosing beta thalassemia trait stops working cleanly.
Hemoglobin A2 (HbA2) is a tiny fraction of the hemoglobin in your blood, normally around 2% to 3% of the total. It gets measured because it goes up in beta thalassemia trait, the inherited condition where one of your two beta-globin genes is broken. A single number above 3.5% does most of the diagnostic work.
The trouble is that several common conditions can push that number in either direction, and a result on the borderline can be either a real carrier or noise.
NutrientsMay 16, 2026
Fatigue has become the modern malaise. Between glowing screens and insufficient rest, the promise of “natural energy” in a capsule is irresistible. Walk into any pharmacy and you’ll find shelves lined with B-complex blends, “energy support” gummies, and vitamin D capsules promising vitality. Yet the human body’s relationship with energy is more chemistry than convenience, and the science behind these supplements is far more nuanced than the slogans suggest.
Cholesterol ManagementMay 16, 2026
The monthly 420 mg Repatha dose delivered by Pushtronex packed three times the medication of the every-two-week shot into a single application, and it lowered LDL cholesterol by roughly 55 to 75%, the same range as the every-two-week schedule. That equivalence was the whole reason the monthly dosing option existed in the first place.
If you remember Pushtronex, you may have used it. If you have not, here is what it was: a hands-free, on-body delivery system that infused the 420 mg monthly dose of Repatha (evolocumab) over a few minutes once you applied it to your stomach or thigh. Amgen has since shifted Repatha distribution toward the SureClick auto-injector and pre-filled syringe formats, but the underlying monthly dosing option that Pushtronex delivered remains.
The question that matters to anyone searching for this is the same now as it was then: did the monthly schedule actually work, and what should you do if you were on it?
AnemiaMay 16, 2026
Most people expect iron supplements to take a long time to kick in. Ferrous gluconate works faster than that. In adults with moderate iron deficiency anemia, taking 150 mg/day of liquid ferrous gluconate raised hemoglobin by at least 0.5 g/dL in roughly 9 to 10 days, with serum iron levels climbing within just 3 days. That's a measurable change before you'd even finish a two-week supply.
Ferrous gluconate is one of several oral iron salts used to treat and prevent iron deficiency anemia (IDA), and the clinical research paints a consistent picture: it's effective across age groups, generally well tolerated, and in some head-to-head comparisons, it outperforms other common iron forms.
GeneticsMay 16, 2026
Lp(a), or Lipoprotein(a), can be thought of as a tiny package of cholesterol in your blood, wrapped in a unique protein called apolipoprotein(a). It's a wildcard in heart health: Lp(a) levels are mostly determined by genes and don't change much with diet or exercise.
High levels of Lp(a) can increase your risk of heart attack, but there's a catch: the amount of risk associated with high levels of Lp(a) depends on your ethnicity.
Cholesterol ManagementMay 16, 2026
In a trial of 27,564 people with established heart disease, Repatha pushed average LDL cholesterol from 92 mg/dL down to 30 mg/dL. That is roughly a 60% drop, achieved on top of statins, sustained for years. The same trial also showed an 18% drop in major cardiovascular events: heart attacks, strokes, and the procedures used to fix them.
Most articles you find about Repatha (evolocumab) are either drug-company brochures or anonymous internet comment threads. The actual reviews you should care about live inside randomized trials and real-world registries that have now followed hundreds of thousands of patient-years on this medication. The picture they paint is consistent: a powerful LDL-lowering injection with a side-effect profile that surprises people for how light it is, paired with hard outcome data that explain why cardiologists keep adding it to high-risk patients despite the price tag.
Cardiovascular HealthMay 16, 2026
Cholesterol is a fatty substance your body uses to build cells and produce hormones. While necessary in the right amounts, excess cholesterol can accumulate in arteries and raise the risk of heart attack and stroke. Traditionally, doctors have focused on LDL (low-density lipoprotein) and HDL (high-density lipoprotein) when evaluating cholesterol levels. However, non-HDL cholesterol is increasingly recognized as a more comprehensive measure of cardiovascular risk.
Non-HDL cholesterol includes all cholesterol particles that are considered atherogenic, meaning they can contribute to plaque buildup in arteries. Knowing your non-HDL cholesterol level provides a clearer picture of your long-term cardiovascular health and may help prevent serious disease.
CancerMay 16, 2026
The next-generation version of Cologuard catches roughly 94% of colorectal cancers from a single stool sample collected on your bathroom counter. That sentence sounds like marketing copy, but it comes from a meta-analysis of 55 studies comparing the multi-target stool DNA test against colonoscopy as the reference standard.
If your doctor has handed you a kit, or you ordered one yourself, the next question is mechanical. What do you actually do with this box? Below is the full set of Cologuard instructions, what each step is checking for, and what the evidence says about how the test performs when used the way it was designed to be used.
MedicationsMay 16, 2026
Fluoxetine, sold as Prozac, is one of the most widely prescribed antidepressants on the planet, and one of the most common fears people have about starting it is gaining weight. But when you look at the actual human trial data, the picture flips. Meta-analyses of randomized trials in overweight and obese adults show fluoxetine produces modest weight loss of roughly 1 to 3 kg compared to placebo, particularly at doses of 60 mg/day or higher over 12 weeks or less. A large systematic review of psychotropic medications found fluoxetine associated with an average 1.3 kg loss.
That's not a typo. The drug most people worry will make them heavier is, if anything, slightly more likely to make them lighter.
CancerMay 16, 2026
Most people learn to watch for the "ABCDE" signs of melanoma: Asymmetry, Border irregularity, Color variation, Diameter, and Evolution. Nodular melanoma frequently fails to trigger any of them. It can be symmetric, uniform in color, even skin-toned or pink. And that mismatch between what you were told to look for and what this cancer actually looks like helps explain a striking statistic: nodular melanoma accounts for only about 14 to 30% of melanoma cases, yet it causes roughly 40 to 45% of melanoma deaths.
The problem is not that nodular melanoma is undetectable. It is that it plays by different rules, and most people, including some clinicians, are scanning for the wrong things.
Weight LossMay 16, 2026
Most of what you lose in your first week of 16:8 intermittent fasting is not fat. Clinical trials consistently show that meaningful, measurable weight loss from time-restricted eating builds over weeks, not days. After just seven days, the research points to changes under 1 kg, driven largely by shifts in water and glycogen rather than real fat reduction.
That doesn't mean the week was wasted. It means you're looking at the opening act, not the finale. Understanding the actual timeline helps you set expectations that won't collapse the moment progress feels slow.
Blood SugarMay 16, 2026
Glucose tablets are a well-established treatment for low blood sugar (hypoglycemia), particularly in individuals with diabetes who take insulin or certain oral medications. These tablets deliver a precise dose of glucose, helping to restore blood sugar levels quickly and effectively. But how do they compare to other carbohydrate sources, and what does current research say about their reliability?
Cardiovascular HealthMay 16, 2026
Only about 16% of cardiologists correctly identify where the V1 electrode should go on your chest. Among paramedics, just 5 to 6% place all six chest leads in the right spots. That is not a typo. The people reading your heart tracings are frequently working with tracings recorded from the wrong locations on your body.
This matters because even a two-centimeter shift in electrode position can alter the squiggly lines on an ECG enough to mimic a heart attack, hide one, or trigger a cascade of unnecessary tests and treatments. Research consistently finds that roughly half or more of ECG recordings in clinical settings have at least one significant lead out of place.
